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Background: Major Depressive Disorder (MDD) is a leading cause of disease burden worldwide. With the
rapid growth of neuroimaging research on relatively small samples, meta-analytic techniques are
becoming increasingly important. Here, we aim to clarify the support in fMRI literature for three leading
neurobiological models of MDD: limbic–cortical, cortico–striatal and the default mode network.
Methods: Searches of PubMed and Web of Knowledge, and manual searches, were undertaken in early
2011. Data from 34 case-control comparisons (n¼1165) and 6 treatment studies (n¼105) were analysed
separately with two meta-analytic methods for imaging data: Activation Likelihood Estimation and
Gaussian-Process Regression.
Results: There was broad support for limbic–cortical and cortico–striatal models in the case-control data.
Evidence for the role of the default mode network was weaker. Treatment-sensitive regions were
primarily in lateral frontal areas.
Limitations: In any meta-analysis, the increase in the statistical power of the inference comes with the
risk of aggregating heterogeneous study pools. While we believe that this wide range of paradigms
allows identiﬁcation of key regions of dysfunction in MDD (regardless of task), we attempted to minimise
such risks by employing GPR, which models such heterogeneity.
Conclusions: The focus of treatment effects in frontal areas indicates that dysregulation here may
represent a biomarker of treatment response. Since the dysregulation in many subcortical regions in the
case-control comparisons appeared insensitive to treatment, we propose that these act as trait
vulnerability markers, or perhaps treatment insensitivity. Our ﬁndings allow these models of MDD to
be applied to fMRI literature with some conﬁdence.
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Major Depressive Disorder (MDD) is a leading cause of disease
burden worldwide (Murray et al., 2013). The study of MDD
with functional neuroimaging techniques has increased year on
year for over a decade but despite many ﬁndings of brain
differences in MDD, we still do not have a clear idea of the neural
aetiology. Various candidate networks have been identiﬁed as
neuroimaging models of MDD. Each has strengths and limitations,
either offering only a partial explanation for the symptoms that
patients experience, or using data generated from Positron Emis-
sion Tomography (PET) evidence (e.g. Mayberg, 1997) with an
associated lack of spatial and temporal resolution. With the
multiple neuroimaging models proposed, summarising the evi-
dence for and against each model in a coherent manner with a
meta-analysis may provide a greater understanding of the relative
merits of each.
The purpose of neuroimaging meta-analysis is to localize the
brain regions that are activated consistently (across a range of
related studies) in response to a certain intervention or in a certain
clinical condition. Meta-analysis imbues greater statistical power
due to the increased number of subjects included and can provide
a more heterogeneous data pool from which to draw conclusions
(Costafreda, 2009). In a recent review, Marchand (2010) notes that
it is unclear whether particular brain changes in depression are a
consequence of symptoms or due to underlying neural vulner-
abilities. Meta-analytic techniques may aid the identiﬁcation of
both state and trait markers. Characterising consistent state
markers may reveal which patients are likely to be sensitive to
treatment. In contrast, describing trait markers would support the
determination of neural vulnerabilities that are associated with
aetiological pathways.
Mayberg's classic neurobiological model (Drevets, 2001;
Mayberg, 2003; Seminowicz et al., 2004) considers MDD in the
context of seven key areas of cortical and limbic dysfunction:
lateral prefrontal cortex, medial prefrontal cortex, orbitofrontal
cortex, subgenual anterior cingulate cortex, rostral anterior cingu-
late cortex, hippocampus and anterior thalamus (Seminowicz
et al., 2004). In this limbic–cortical model, over-activity in limbic
areas (including the hippocampus) is not adequately controlled by
prefrontal areas, with an associated depressed mood (Mayberg
et al., 1999). The rostral and subgenual regions of the anterior
cingulate cortex are believed to play a key mediatory role in this
network (Disner et al., 2011; Seminowicz et al., 2004) which is also
employed during emotion processing in healthy volunteers
(Phillips et al., 2003; Stevens and Hamann, 2012).
An alternative model places greater emphasis on the role of
subcortical structures in the aetiology of depression. The concept
of parallel, overlapping, cortico–striato–pallidal–thalamic loops
was introduced by Alexander et al. (1986). Circuits extend from
the striatum to prefrontal and limbic regions and are involved in
separable functions including cognitive and emotional processing
and motor control. Striatal dysfunction in particular has been
associated with symptoms of MDD including anhedonia and
psychomotor retardation and grey-matter volume reductions havebeen shown throughout regions of this network in MDD (Bora
et al., 2012).
Patients with current MDD frequently score highly on scales of
negative mood valent rumination (Mor and Winquist, 2002), with
associated heightened depressive symptom load and hyperactivity
in the default mode network (Pizzagalli, 2011). This dispersed
network includes medial prefrontal regions, precuneus, lateral
parietal cortex and the lateral temporal cortex (Raichle et al.,
2001). These areas show increased activity at rest in current MDD
(Greicius et al., 2007) along with a failure to deactivate normally
during task conditions (Shulman et al., 1997). This model, based on
a cognitive rumination process, is thought to best represent a
state-dependent feature and may, in part, account for maintenance
of an episode.
There are two main approaches to meta-analysis of functional
imaging studies: image-based and coordinate-based. Image-based
meta-analysis uses the voxel-wise estimates of effect size from
each contributing study. However, although less accurate (Salimi-
Khorshidi et al., 2009), coordinate-based meta-analysis methods
have become the standard approach since they require only the
locations of peak activations as reported in the literature. In this
study we employed both Activation Likelihood Estimation (ALE)
(Eickhoff et al., 2009; Laird et al., 2005; Turkeltaub et al., 2002)
and Gaussian-process regression (GPR) (Salimi-Khorshidi et al.,
2011) coordinate-based meta-analyses. ALE models peak activa-
tions as probability distributions with widths that estimate the
spatial uncertainty due to the between-subject and between-
template variability. GPR enables a coordinate-based meta-analy-
sis to incorporate coordinates and their (both positive and nega-
tive) effect sizes, modelling the intervening regions between the
reported peak activations to produce an estimate of the combined
effect-size at every intracerebal voxel.
In previous meta-analyses of MDD data with ALE, there was
broad support for all of the regions in the aforementioned three
models implicated in MDD, although the direction of effects was
unclear. These previous analyses have variously used a mixture of
PET, SPECT and fMRI data (Delaveau et al., 2011; Diener et al., 2012;
Fitzgerald et al., 2008a, 2006; Fu et al., 2012; Sacher et al., 2012;
Steele et al., 2007) and focused on speciﬁc paradigms (Delaveau
et al., 2011; Diener et al., 2012; Fitzgerald et al., 2008a; Hamilton
et al., 2012) or brain regions (Fitzgerald et al., 2006; Steele et al.,
2007). This methodology excludes many otherwise eligible
studies which are ruled out and their data lost. More importantly,
although PET and fMRI can give similar results, the two methods
measure fundamentally different phenomena and it is clear that
one cannot always predict the other (Kinahan and Noll, 1999).
The meta-analytic study reported here seeks to clarify the
support for each model speciﬁcally in the fMRI literature, and to
investigate the possible interplay between them, using case-
control comparisons and treatment studies with a broad range
of study designs. It is hypothesised that support will be shown for
all models described. We consider that the default mode network
in particular will show a decrease in activity with treatment,
indicating that regions of this network are a putative state marker
for depression and may index differential treatment response.
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linked with trait vulnerability and be less affected by treatment.2. Methods and materials
Where possible, the recommendations of Stroup et al. (Stroup
et al., 2000) for reporting meta-analyses were followed. Where
deviations from this framework occurred, these were due to the
particular characteristics and requirements of a neuroimaging-
based meta-analysis.
2.1. Study identiﬁcation
A comprehensive literature search was conducted using the
search terms “(Depression OR major depressive disorder OR mood
disorder OR MDD) AND (brain imaging OR fMRI OR magnetic
resonance imaging)”. The PubMed and Web of Knowledge data-
bases were searched in early 2011 and reference lists of included
papers and relevant review papers were also scrutinised. Where
full-text papers could not be accessed, or data was inadequate,
efforts were made to contact authors and obtain these data.
Included studies were in two categories – those that compared
MDD patients and healthy controls at one time point (for the
cross-sectional study) and those that compared patients before
and after treatment of any kind. Treatment studies that also
provided a baseline case-control comparison were placed in both
groups. All included studies were agreed by consensus between at
least two members of the study team (JG, CH, BL and JS) according
to the following criteria:(1) Study published in English
(2) Brain imaging using functional MRI only
(3) Standard Talairach or MNI spatial co-ordinates and statistical
signiﬁcance values for case-control or pre–post treatment
comparison provided for each cluster(4) Whole brain analysis conducted
(5) Adult (but not late-life) patients with a diagnosis of unipolar
depression not included in a group with bipolar depression2.2. Analysis
Four separate analyses were conducted, two in each of the
case-control (cross-sectional) and treatment datasets. Data from
each study were summarised as a set of foci (i.e. XYZ coordinates),
along with study sample size and (standardised) effect sizes. These
data were analysed using both ALE and GPR meta-analytic tech-
niques. While the former approach only uses the coordinates and a
study size parameter, the latter approach incorporates both
coordinates and their effect sizes.
The ALE technique (Eickhoff et al., 2009; Laird et al., 2005;
Turkeltaub et al., 2002) carries out voxel-wise hypothesis testing,
using the test statistic “the probability of at least one peak/foci at a
voxel”, and null hypothesis “H0: no peaks truly activate at this
voxel”. Thus, its signiﬁcant result at a voxel can be interpreted as
“one or more peaks lie at this voxel” (Turkeltaub et al., 2002;
Wager et al., 2007). In this ALE analysis, all co-ordinates were ﬁrst
registered into standard Montreal Neurological Institute stereo-
tactic space using the tal2icbm algorithm (Laird et al., 2005)
integral to the GingerALE 2.1 software (Eickhoff et al., 2009;
Turkeltaub et al., 2012). The coordinates were then used to
conduct an analysis of both cross-sectional and treatment data,
run separately. For each study, a Gaussian ﬁlter was used to
produce a voxel-wise activation likelihood statistic from its peak
coordinates. The size of this ﬁlter is determined empirically,weighted by the number of subjects per study and estimates of
between-subject variability. We employed “random effects” ALE to
combine the study maps and produce the meta-analysis statistic
image which, when tested against the null hypothesis, resulted in
a P-value map. We then thresholded this P-value map at the false
discovery rate of Po0.05, and only considered the clusters with a
minimum size of 200 mm3. Note that ALE requires the analyses for
activation and deactivation in each condition to be conducted
separately.
Our next approach, GPR, is an attempt to overcome the
problems common among coordinate-based meta-analysis tech-
niques such as ALE (Salimi-Khorshidi et al., 2011). It incorporates
both the collected foci and their associated effect-sizes, hence
explicitly estimating the unobserved statistic image. Employing a
hierarchical model similar to those used by image-based meta-
analysis techniques enables the GPR to result in a proper random-
effects meta-analysis. GPR is essentially a nonparametric regres-
sion model that assumes that the foci collected from source data
are noisy observations from the statistic image that a meta-
analysis aims to estimate. Assuming that this underlying image
is smooth (i.e., nearby voxels are likely to have similar statistic
values), GPR uses the effect-sizes at the location of the empirical
foci to predict the effect-sizes at the voxels that have no informa-
tion associated with them (i.e., the prediction phase). Before this,
however, GPR learns the extent of the smoothness (equivalent of
ALE's kernel size), and the variances of the signal (i.e., the variance
of the effect-size image) and random-effects noise (i.e., inference
phase). The mathematical details of this process are described in
Appendix 1.3. Results
3.1. Study identiﬁcation
Fig. 1 indicates the sequence of inclusions during study identi-
ﬁcation. The papers included in the ﬁnal analysis can be found in
Table 1. Reasons for exclusion of studies were various: no main effects
presented; sample overlap with another included paper; no co-
ordinates presented; inappropriate analysis technique; no effect size
statistics presented; no appropriate group comparisons; not MDD;
paediatric sample; not fMRI. In addition, a number of studies could not
be included due to no whole-brain differences being observed. Studies
conducting only Region of Interest analysis were also excluded.
3.2. Analysis
The outcomes of the two ALE and two GPR analyses are
summarised in Table 2. Full results including coordinates and
effect sizes are available in the Supplementary material.
3.2.1. Case-control studies
ALE analysis found increases in activation in current MDD
patients at baseline were found in the following regions: left and
right middle temporal gyri, left inferior frontal gyrus, left sub-
genual anterior cingulate, left precentral gyrus, left thalamus, left
middle frontal gyrus; and decreases in activity were found in:
right middle frontal gyrus, right parahippocampus, left inferior
frontal gyrus, left and right caudate, right superior and middle
temporal gyrus, right anterior cingulate cortex, right insula, right
amygdala, and left occipital regions. In the GPR analysis of the
same data, increases in activity were found in the following
regions: bilateral inferior frontal gyrus, right superior frontal
gyrus, left middle frontal gyrus, left insula, bilateral anterior
cingulate cortex, bilateral precuneus, right subgenual anterior
cingulate cortex, right lateral temporal cortex, left orbitofrontal
Screening of abstract 
n=1337 
Consensus agreement 
Screening of full-text 
N=39 unique papers  
n=126 
Treatment 
n=6 
105 participants 
n=1201 excluded 
not meeting criteria 
n=87 excluded: 
not meeting criteria* 
*inc. no wholebrain differences  
n=4 
Cross section 
n=34 
1165 participants 
Fig. 1. Flowchart of inclusion process for cross-sectional and treatment studies. Identical set analysed with GPR and ALE methods. GPR: Gaussian-process regression. ALE:
Activation Likelihood Estimation.
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campus, right globus pallidus, bilateral precentral gyrus, right
posterior cingulate cortex, left temporal pole, and right lateral
parietal and left lateral occipital regions. From the same model,
decreases in activity were found in: bilateral caudate, right dorsal
lateral prefrontal cortex, bilateral medial prefrontal cortex, right
parahippocampus, right thalamus, left rostral anterior cingulate
cortex, right middle temporal gyrus, left nucleus accumbens, left
inferior frontal gyrus, right middle frontal gyrus, right supplemen-
tary motor cortex, right amygdala, left superior temporal gyrus
and middle temporal gyrus, left precentral gyrus, left lingual gyrus,
and bilateral occipital regions.
3.2.2. Treatment studies
In ALE analysis of treatment data, decreases in activity with
treatment were found in left superior temporal gyrus and left
cerebellar areas. With GPR, increases were found in left precentral
gyrus, left precuneus and right dorsal lateral prefrontal cortex,
while decreases were found in left precuneus, bilateral dorsal
lateral prefrontal cortex, left lateral occipital regions.4. Discussion
In this study we conducted a series of meta-analyses to probe the
available imaging evidence for extant neurobiological models of
depression. With data from case-control comparisons there was
broad support from both meta-analytical techniques for limbic–
cortical and cortico–striato–pallidal–thalamic models, and some sup-
port for the role of the default mode networks (Fig. 2). These models
should therefore be applied to fMRI data with some conﬁdence.Meta-analysis revealed that effects of treatment were primarily
in lateral frontal regions, with support for both increases and
decreases in activation of neighbouring regions of the dorsal
lateral prefrontal cortex following treatment. This implicates
frontal areas as state markers of MDD. Although this is contrary
to previous work indicating that subcortical and limbic regions are
also inﬂuenced by treatment (Delaveau et al., 2011), those ﬁndings
may be inﬂuenced by the ROI analyses in included studies, or by
the inclusion of data from PET alongside fMRI ﬁndings. That
striatal regions are dysfunctional in current MDD, and that this
activity does not change with treatment, supports the role of these
regions as trait vulnerability markers.
Interestingly, the ﬁndings further suggest that frontal, espe-
cially lateral frontal, changes are putative state markers and linked
more closely to the negative mood state, as the latter are more
clearly altered by treatment. An alternative explanation may be
that those areas left unchanged by treatment indicate a neural
marker of treatment resistance. Since the included treatment
studies reported between 70–100% response rates where data
were available, this seems less likely but cannot be fully dis-
counted. Primary damage to the striatum can precipitate a
depressive episode (Folstein et al., 1985), and this region is a
successful target for Deep Brain Stimulation for MDD (Anderson
et al., 2012; Malone et al., 2009), supporting its key role in the
aetiology of MDD. If striatal dysfunction does contribute to trait
vulnerability, and since the striatum lies at the heart of the
cortico–striato–pallidal–thalamic model, it may be said that this
model may more closely account for the aetiology of MDD.
It is important to consider the roles of key regions implicated in
these analyses that are not included within the prevailing models
of MDD including distributed occipital areas, insula, the
Table 1
(a) Characteristics of studies included in the cross-sectional meta-analyses.
Study Patient N Control N Paradigm type
Bar et al. (2007) 13 13 Other
Canli et al. (2004) 15 15 Emotional
Cooney et al. (2010) 14 14 Emotional
Davey et al. (2011) 19 20 Emotional
Eddington et al. (2009) 22 14 Other
Elliott et al. (2002) 10 11 Emotional
Epstein et al. (2006) 10 12 Emotional
Fitzgerald et al. (2008b) 13 13 Cognitive
Gotlib et al. (2005) 18 18 Emotional
Grimm et al. (2009) 19 29 Emotional
Hugdahl et al. (2007) 9 12 Cognitive
Langenecker et al. (2007) 16 17 Cognitive
Lopez-Sola et al. (2010) 13 20 Other
Matsuo et al. (2007) 15 15 Cognitive
Matthews et al. (2009) 15 16 Cognitive
McCabe et al. (2009) 13 14 Other
Mitterschiffthaler et al. (2008) 17 17 Cognitive
Naismith et al. (2010) 19 20 Other
Norbury et al. (2010) 16 21 Emotional
Okada et al. (2003) 10 10 Cognitive
Pizzagalli et al. (2009) 30 31 Cognitive
Ritchey et al. (2011) 22 14 Emotional
Scheuerecker et al. (2010) 13 15 Emotional
Schoning et al. (2009) 28 28 Cognitive
Strigo et al. (2008) 15 15 Other
Surguladze et al. (2010) 9 9 Emotional
Taylor Tavares et al. (2008) 9 12 Cognitive
Townsend et al. (2010) 15 15 Emotional
Victor et al. (2010) 22 25 Emotional
Walter et al. (2007) 12 17 Cognitive
Wang et al. (2008) 19 20 Emotional
Wu et al. (2011) 44 26 Resting state
Yang (2004) 10 10 Other
Yao et al. (2009) 22 22 Resting state
(b) Characteristics of studies included in the treatment meta-analysis. TMS: transcranial magnetic stimulation.
Study Patient N Control N Paradigm type Treatment
Dichter et al. (2010) 12 15 Emotional Brief behavioural activation therapy
Fitzgerald et al. (2007) 26 – Cognitive Low-frequency TMS
Frodl et al. (2011) 24 15 Emotional Mirtazapine/venlafaxine
Lopez-Sola et al. (2010) 13 20 Other Duloxetine
Robertson et al. (2007) 10 – Emotional Bupropion
Wagner et al. (2010) 20 20 Cognitive Citalopram/reboxetine
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lobes showed over-activity in MDD in the case-control analysis
and a decrease with treatment. This pattern may be due to the
effects of low-level visual processing biases as a result of low
mood. Alternatively, and consistent with current evidence, altera-
tions in occipital structure are associated with co-occurring
anxiety (Adenauer et al., 2010; Bruhl et al., 2011; Goddard et al.,
2001). Therefore we suggest that occipital dysregulation, and
subsequent normalisation with treatment, found in this meta-
analysis is due to increased anxiety symptoms or co-occurring
disorders during an episode of MDD. In contrast, regions of the
cerebellum were hypoactive in the case-control meta-analysis and
did not change with treatment. This may indicate a more persis-
tent trait-level dysfunction perhaps emerging during early devel-
opment and prior to the ﬁrst episode of illness. Further work is
required to determine the inﬂuence of occipital and cerebellar
regions in the aetiology of MDD.
While many regions showed the directional changes predicted
by existing models, for example subgenual anterior cingulate
hyperactivity (Sacher et al., 2012), these meta-analyses have also
highlighted some key contradictions. At the forefront of these is
the ﬁnding that right amygdala activity is selectively decreased inMDD. This is contrary to the propositions of the limbic–cortical
model which suggest the amygdala to be hyperactive in depres-
sion (Drevets, 1998). Both the ALE and GPR meta-analyses found
amygdala hypoactivity, indicating strong concordance and thus
permitting greater conﬁdence. This ﬁnding requires further
exploration to determine the association with particular charac-
teristics of MDD such as the number of prior episodes, and the
duration and severity of the current episode. This cannot be
ascertained without greater speciﬁcity of the clinical phenotype
and distinguishing activation and deactivation between vulnerable
never ill, ﬁrst episode, recurrent and chronic treatment resistant
MDD cases.
We have shown, in support of previous studies, that the GPR
provides a higher level of sensitivity compared with other
coordinate-based meta-analysis techniques (Salimi-Khorshidi
et al., 2011). Thus, we advocate the use of GPR coordinate-based
meta-analysis for studies that provide both coordinates and their
effect sizes. However, performing an ALE analysis in addition to
the GPR has two advantages: (1) it provides a result that can be
more readily compared with previous analyses using ALE; and
(2) it provides a relatively conservative meta-analysis with a low
risk of false positive results.
Table 2
Summary of ﬁndings in cross-sectional and treatment ALE and GPR meta-analyses.
dlPFC: dorsolateral prefrontal cortex. rACC: rostral anterior cingulate cortex. sgACC:
subgenual anterior cingulate cortex. OFC: orbitofrontal cortex. HC: hippocampus.
mPFC: medial prefrontal cortex. STN: subthalamic nucleus. AMG: amygdala.
vmPFC: ventromedial prefrontal cortex. dmPFC: dorsomedial prefrontal cortex.
PCC: posterior cingulate cortex. GPR: Gaussian-process regression. ALE: Activation
Likelihood Estimation.
Model Region X-section Treatment
GPR ALE GPR ALE
Cortico–striatal–pallidal–thalamic
loops
Striatum ↓ ↓
Pallidum ↑
Thalamus ↑↓ ↑
STN
mPFC ↑↓
lPFC ↑↓ ↑↓ ↑↓
HC ↑ ↓
AMG ↓ ↓
Limbic–cortical dysregulation lPFC ↑↓ ↑↓ ↑↓
Anterior
thalamus
↓
rACC ↓ ↓
sgACC ↑ ↑
OFC ↑
HC ↑ ↓
mPFC ↑↓
Default mode network vmPFC ↑↓
dmPFC ↓
PCC/
retrosplenial
↑ ↑
Inferior parietal ↑
Lateral temporal ↑↓ ↓
Hippocampal ↓
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limitations in the current design that merit discussion. First, we were
unable to include four studies in the analysis since they found no
wholebrain differences. Although GPR aims to account for this
phenomenon by modelling report censoring (see Appendix 1), it is
likely that there were other, unpublished, negative studies. This will
result in a clear but currently unavoidable bias in the ﬁndings.
Second, the data in these meta-analyses were derived from hetero-
geneous paradigms and treatment methods. For example, inclusion
of a majority of task-orientated and two resting-state functional
studies may have inﬂuenced our relative lack of support for the
Default Mode Network model, since opposing ﬁndings would have
been expected in each condition (Pizzagalli, 2011). By adopting less
restrictive inclusion criteria the power permissible was greatly
increased, and there is an inevitable trade-off between power and
speciﬁcity. The current study aimed to investigate consistent regions
of dysfunction in MDD across task-type, rather than identify corre-
lates of dysfunction in speciﬁc functional tasks. This approach
permits greater generalizability of the ﬁndings to broad neurobiolo-
gical models. In addition, the treatment analyses included a range of
treatment classes and functional paradigms. The paucity of research
in this area in part necessitated an inclusive approach, however the
ﬁndings should be considered in the context of biomarkers of
treatment response where the precise treatment class may be
of less signiﬁcance than symptom improvement. Biomarkers of
treatment response shed light on the neurobiological mechanisms
of pathology in this instance. To our knowledge, these are the
ﬁrst meta-analyses to include exclusively fMRI data from a broad
range of paradigms and the results demonstrate that inﬂuential
neurobiological models based in part on resting-state PET literature
are also applicable to fMRI ﬁndings.A more endemic difﬁculty is the inclusion of data for a hetero-
geneous patient group. There is a large degree of variation in the
phenotypic presentation of MDD with, for example, melancholia,
psychotic depression and post-natal depression felt to represent
distinct sub-types of the condition (Harald and Gordon, 2012).
Indeed, the validity of the diagnosis of MDD across the life course
is problematic. This is likely to be improved in future studies with the
application of formal mathematical models to enhance validity of the
clinical phenotype for these heterogeneous disorders (Cole et al.,
2011; Goodyer, 2012). With this in mind, it is not clear that a single
neural model of MDD can be applied and it is instead possible that
with disaggregation of the clinical subtypes in the future, more
consistent neurobiological models may be possible.
In summary, a meta-analytic description of the neurobiology of
depression from functional MRI both provides support for pre-
vious models, but also suggests important differences. By assessing
the available evidence in a model-free (i.e. whole brain) context,
further novel regions associated with MDD have been identiﬁed,
particularly in the occipital cortex and cerebellum. A detailed
understanding of the evidence for these models is a step towards a
more integrated “meta-model” of the depressions as a whole.Role of funding source
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Suppose the full-image study-level data were available, then
for study s at voxel k, the contrast estimates can be modelled as
ys;k ¼ μk þws;k; ð1Þ
where ws;k∼N ð0; s2s;k þ τ2k Þ, μk denotes the overall population mean
(i.e., what meta-analysis is expected to estimate), ss;k is within-
study standard deviation, τk is inter-study standard deviation and
ws;k is the observation/reporting error at study s and voxel k.
Typically coordinate-based meta-analysis does not have access
to study-level y and s at every voxel; instead it has access
to sparsely sampled standardized effect sizes (i.e., z¼y/s). This
changes reformulates the model to
zs;k ¼ μk=ss;k þ εs;k; ð2Þ
where εs;k  N ð0;1þ τ2k=s2s;kÞ. If we assume that every study has
the same s image (i.e., studies are similarly reliable in their effect-
size estimates), then the model can be rewritten as
zs;k ¼ mk þ εs;k; ð3Þ
where mk ¼ μk=sk, εs;k  N ð0;1þ v2k Þ and v2k ¼ τ2k=sk.
Even though coordinate-based meta-analysis only has access to
n sparsely-located samples of Z-stat image (z¼(z1,z2,…,zn)) with
Fig. 2. Summary of selected evidence for each network in the both the GPR and ALE data as presented in the case-control comparison. Contrasts are MDD-controls, with red
indicating hyperactivity in MDD and blue indicating hypoactivity in MDD. 1, dorsal prefrontal cortex (PFC); 1 m, dorsal medial PFC; 2, ventral PFC; 2 m, ventral medial PFC; 3,
orbitofrontal cortex; 4, anterior cingulate cortex; 5, caudate; 6, putamen; 7, globus pallidus; 8, thalamus; 8a, anterior thalamus; 9, rostral ACC; 10, subgenual ACC; 11,
hippocampus; 12, lateral temporal cortex; 13, posterior cingulate cortex; 14, lateral parietal cortex.
J. Graham et al. / Journal of Affective Disorders 151 (2013) 423–431 429their corresponding voxel coordinates V¼{v1, v2,…, vn}, we can
employ Gaussian-process regression to model those voxels' (unob-
served) standardized mean effect size m. Under Gaussian-process
regression, m is assumed to be a sample from a Gaussian process,
i.e., m GPð0; CÞ with C denoting the covariance matrix of the
Gaussian process. We employ a squared exponential covariance
function whose shape can be described with two hyperparameters
rf (describing m's variance) and λ (describing m's smoothness).
Assuming that z is sampled from m with an additive Gaussian
noise of N ð0; s2nÞ distribution, results in
zk  N ðmk; s2nÞ; ð4Þ
in which sn estimates 1þ τ2k=s2s;k.
In the ﬁrst step of this solution (inference), the model's hyper-
parameters (rn, rf, and λ) are estimated using evidence optimization.
These estimates are used in the second step (prediction) to predict
the full m map. We incorporate our prior knowledge about statistic
images' smoothness by employing a Gamma prior (with mean 2 mm
and SD of 5 mm) on λ in order to minimize the likelihood of an
extremely high or low smoothness. Also, instead of estimating the rf
using evidence optimization, we use a ﬁxed rf¼3, in order to force
the desired behaviour ofm when away from observations. This ﬁxed
value implies the extent of censoring/uncertainty in voxels that haveno reported foci. The full details of Gaussian-process regression
coordinate-based meta-analysis can be found in (18).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.jad.2013.07.002.References
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